These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 10221439)
1. The effect of intranasal and inhaled corticosteroids in healthy volunteers on the number of circulating lymphocytes and lymphocyte subsets. Fokkens WJ; van de Merwe JP; Braat JP; Overbeek SE; Hooijkaas H Allergy; 1999 Feb; 54(2):158-64. PubMed ID: 10221439 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of epimeric budesonide and fluticasone propionate after repeat dose inhalation--intersubject variability in systemic absorption from the lung. Minto C; Li B; Tattam B; Brown K; Seale JP; Donnelly R Br J Clin Pharmacol; 2000 Aug; 50(2):116-24. PubMed ID: 10930963 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function. Nielsen LP; Dahl R Am J Respir Crit Care Med; 2000 Dec; 162(6):2053-7. PubMed ID: 11112113 [TBL] [Abstract][Full Text] [Related]
4. Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma. Lee DK; Jackson CM; Currie GP; Cockburn WJ; Lipworth BJ Br J Clin Pharmacol; 2003 Nov; 56(5):494-500. PubMed ID: 14651722 [TBL] [Abstract][Full Text] [Related]
5. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma. FitzGerald JM; Boulet LP; Follows RM Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813 [TBL] [Abstract][Full Text] [Related]
6. Salmeterol and fluticasone propionate given as a combination. Lack of systemic pharmacodynamic and pharmacokinetic interactions. Kirby S; Falcoz C; Daniel MJ; Milleri S; Squassante L; Ziviani L; Ventresca GP Eur J Clin Pharmacol; 2001; 56(11):781-91. PubMed ID: 11294367 [TBL] [Abstract][Full Text] [Related]
7. A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler. Grahnén A; Jansson B; Brundin RM; Ling-Andersson A; Lönnebo A; Johansson M; Eckernäs SA Eur J Clin Pharmacol; 1997; 52(4):261-7. PubMed ID: 9248762 [TBL] [Abstract][Full Text] [Related]
8. Adrenocortical activity with repeated administration of one-daily inhaled fluticasone propionate and budesonide in asthmatic adults. Wilson AM; Clark DJ; Devlin MM; McFarlane LC; Lipworth BJ Eur J Clin Pharmacol; 1998 Jan; 53(5):317-20. PubMed ID: 9516029 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in healthy volunteers. Mackie AE; McDowall JE; Falcoz C; Ventresca P; Bye A; Daley-Yates PT Clin Pharmacokinet; 2000; 39 Suppl 1():23-30. PubMed ID: 11140430 [TBL] [Abstract][Full Text] [Related]
11. Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function. Sheth KK; Cook CK; Philpot EE; Prillaman BA; Witham LA; Faris MA; Klein KC; Rickard KA Allergy Asthma Proc; 2004; 25(2):115-20. PubMed ID: 15176496 [TBL] [Abstract][Full Text] [Related]
12. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma. Derom E; Van Schoor J; Verhaeghe W; Vincken W; Pauwels R Am J Respir Crit Care Med; 1999 Jul; 160(1):157-61. PubMed ID: 10390394 [TBL] [Abstract][Full Text] [Related]
13. Assessment of the relative systemic potency of inhaled fluticasone and budesonide. Boorsma M; Andersson N; Larsson P; Ullman A Eur Respir J; 1996 Jul; 9(7):1427-32. PubMed ID: 8836654 [TBL] [Abstract][Full Text] [Related]
14. Lung deposition and systemic availability of fluticasone Diskus and budesonide Turbuhaler in children. Agertoft L; Pedersen S Am J Respir Crit Care Med; 2003 Oct; 168(7):779-82. PubMed ID: 12893646 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects. Harrison TW; Wisniewski A; Honour J; Tattersfield AE Thorax; 2001 Mar; 56(3):186-91. PubMed ID: 11182010 [TBL] [Abstract][Full Text] [Related]
16. Short-term knemometry and urine cortisol excretion in children treated with fluticasone propionate and budesonide: a dose response study. Agertoft L; Pedersen S Eur Respir J; 1997 Jul; 10(7):1507-12. PubMed ID: 9230238 [TBL] [Abstract][Full Text] [Related]
17. An assessment of the systemic effects of single and repeated doses of inhaled fluticasone propionate and inhaled budesonide in healthy volunteers. Lönnebo A; Grahnén A; Jansson B; Brundin RM; Ling-Andersson A; Eckernäs SA Eur J Clin Pharmacol; 1996; 49(6):459-63. PubMed ID: 8706770 [TBL] [Abstract][Full Text] [Related]
18. An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers. Grahnén A; Eckernäs SA; Brundin RM; Ling-Andersson A Br J Clin Pharmacol; 1994 Dec; 38(6):521-5. PubMed ID: 7888290 [TBL] [Abstract][Full Text] [Related]
20. Effects of inhaled corticosteroids on growth in asthmatic children: a comparison of fluticasone propionate with budesonide. Acun C; Tomac N; Ermis B; Onk G Allergy Asthma Proc; 2005; 26(3):204-6. PubMed ID: 16119035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]